Bone fracture as a novel immune‐related adverse event with immune checkpoint inhibitors: Case series and large‐scale pharmacovigilance analysis-Reference-Cited by-同舟云学术

Bone fracture as a novel immune‐related adverse event with immune checkpoint inhibitors: Case series and large‐scale pharmacovigilance analysis

Published:2021-05-04 Issue:3 Volume:149 Page:675-683
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Filippini Daria Maria¹²³,Gatti Milo⁴^ORCID,Di Martino Vito¹,Cavalieri Stefano¹,Fusaroli Michele⁴,Ardizzoni Andrea³,Raschi Emanuel⁴,Licitra Lisa¹

Affiliation:

1. Head and Neck Medical Oncology Unit Fondazione IRCCS—Istituto Nazionale dei Tumori Milan Italy

2. Department of Oncology and Hemato‐Oncology University of Milan Milan Italy

3. Medical Oncology Unit, Department of Experimental, Diagnostic and Specialty Medicine Policlinico S. Orsola‐Malpighi, Alma Mater Studiorum—University of Bologna Bologna Italy

4. Pharmacology Unit, Department of Medical and Surgical Sciences Alma Mater Studiorum—University of Bologna Bologna Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33592

Reference25 articles.

1. Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape

3. Increased reporting of fatal hepatitis associated with immune checkpoint inhibitors

4. Immune checkpoint inhibitor–associated hypophysitis—World Health Organisation VigiBase report analysis

5. Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer treatment-induced bone loss;The Korean Journal of Internal Medicine;2024-09-01

2. Increase in major osteoporotic fractures after therapy with immune checkpoint inhibitors;BMJ Oncology;2024-08

3. Determining fracture risk in patients exposed to immune checkpoint inhibitors: the time is now;BMJ Oncology;2024-08

4. Osteoporotic fractures: an unrecognized adverse event of immune checkpoint inhibitors?;Journal for ImmunoTherapy of Cancer;2024-07

5. Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors;Frontiers in Immunology;2024-04-18